Trials / Completed
CompletedNCT07078071
Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 199 (actual)
- Sponsor
- Huawei Device Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to validate the efficacy and safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software (Huawei Device Co., Ltd.). This software can provide alerts, store and display PPG data transmitted from smartwatches or fitness trackers. The software is limited to alerting of atrial fibrillation and premature beat, and the results are only for clinical reference.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ECG | Each participant undergoes testing with both the investigation device and the control device simultaneously. The results of the investigation device, which are obtained through pulse wave data analysis at the wrist, are compared to the investigator's interpretation of the ECG. |
Timeline
- Start date
- 2022-10-18
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2025-07-22
- Last updated
- 2025-07-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07078071. Inclusion in this directory is not an endorsement.